Understanding exactly what happens during luxury detox can ease anxiety and help you prepare. Here's a step-by-step guide to the luxury detox process at Sanctuary Tulum.
Step 1: Comprehensive Medical Assessment
Before detox begins, our medical team conducts thorough evaluations including blood panels, liver function tests, EKG, and psychological assessment. This ensures your detox protocol is perfectly calibrated to your needs.
Step 2: Supervised Withdrawal with Advanced Support
The withdrawal phase is managed with 24/7 medical supervision. NAD+ IV drips, amino acid infusions, and high-dose vitamin protocols dramatically reduce discomfort while accelerating your body's natural detoxification.
Step 4: Transition to Comprehensive Healing
Detox is the foundation. From here, you transition into deeper healing at our luxury rehab — which may include medically supervised ibogaine treatment, ayahuasca ceremonies, and other powerful modalities.

Phase 1 — Medical Intake and Baseline
Before any therapy begins, guests complete a medical intake covering history, current medications, and substance-of-use timeline. Labs (CBC, comprehensive metabolic panel, liver function, electrolytes) and an ECG establish baseline. For alcohol, withdrawal risk and severity are tracked against the clinical picture described in NIAAA's guidance on alcohol use disorder;1 for benzodiazepines, the same baseline work identifies dose, duration of use, and half-life, all of which determine how a taper must be structured.
Phase 2 — Acute Stabilization
The first 72–96 hours are the highest-risk window for most substances. Vitals are monitored frequently, and for alcohol, symptom-triggered management follows the practical framework described in current hospital-based reviews of alcohol withdrawal syndrome.2 IV protocols during this phase focus on repletion — thiamine, magnesium, B-complex — and neurochemical support with NAD+ and amino acid infusions.
Sleep, nutrition, and hydration are managed as clinical variables. Guests are in private suites with blackout capability so circadian regulation begins recovering immediately.

Phase 3 — Cellular Repair and Handoff
Once acute withdrawal has resolved, the program shifts toward cellular and neurochemical recovery: continued NAD+, glutathione, hyperbaric oxygen (HBOT), red light, targeted nutrition, and gentle movement. Guests transition into the broader luxury rehab center arc — the point of detox is to make that work possible, not to be an endpoint on its own. Structured continuing care measurably improves the odds that stabilization holds,3 which is why the aftercare plan starts being drafted during Phase 3, not on discharge day.
Why Benzodiazepine and Alcohol Withdrawal Are Never Rushed
Not every substance detoxes on the same clock, and two categories in particular — benzodiazepines and alcohol — require a materially slower, physician-led approach than stimulants or most opioids. The FDA's boxed warning on the benzodiazepine drug class specifically flags the risks of dependence and withdrawal, and directs prescribers toward gradual, individualized dose reduction rather than abrupt discontinuation.4 Hyperbolic tapering — reducing the dose by a proportion of the current dose rather than by a fixed amount — is the pharmacological principle behind why some benzodiazepine tapers slow down considerably near the end rather than accelerating.5
A modified Delphi consensus among prescribers who specialize in deprescribing long-term benzodiazepine use converges on the same point: dose reduction should be paced to the individual's receptor adaptation and withdrawal symptoms, not to an external deadline.6 StatPearls' clinical reference on benzodiazepine withdrawal management describes the same risk profile — seizures, delirium, and in rare cases life-threatening complications when discontinuation is abrupt or unsupervised7 — which is why our protocols never include a fixed rapid-taper timeline for this class of medication. The same logic applies to alcohol: the physiological dependence that builds after sustained heavy use means a supervised, gradually managed withdrawal is safer than an abrupt stop, a principle reflected throughout NIAAA's clinical guidance on alcohol use disorder.1
What the Second and Third Weeks Look Like
Beyond acute stabilization, weeks two and three focus on the collateral load that long-term substance use creates: sleep architecture, HPA-axis regulation, cognition, and gut function. Guests continue on IV protocols on a tapering schedule while adjunct modalities — HBOT, red light, bodywork, colon hydrotherapy — layer in. Movement and breathwork are introduced progressively so the nervous system relearns regulation without pharmacological support.
Aftercare planning begins in earnest in week two: coordinated handoff to a physician at home, a maintenance nutrition and IV protocol, and structured integration check-ins. Related: what to expect at luxury rehab.
Guests frequently ask what makes recovery hold once they leave. The variables that show up consistently in psychosocial-intervention research for inpatient substance use treatment are structured aftercare, continuity of a treating physician at home, sleep regularity, and a written relapse-prevention plan the guest actually helped draft.8 Sanctuary Tulum builds all four into discharge, and offers scheduled follow-up touchpoints — as brief phone check-ins or return booster stays — for the first year post-program.
The First 72 Hours — What Actually Happens
Hour zero is arrival, intake vitals, a full medication reconciliation, bloodwork (CBC, comprehensive metabolic panel, LFTs, magnesium, phosphorus), and an initial physician assessment. IV thiamine goes in before any glucose in any alcohol presentation. Hydration and electrolyte correction start within the first hour. For guests arriving already on a benzodiazepine prescription, no dose change happens on day one — the taper schedule is built from the intake data and reviewed by the physician before any adjustment is made.
Hours 12 through 72 are typically the peak withdrawal window for alcohol and are managed with close vital-sign monitoring, symptom-focused clinical review, and titrated support rather than a fixed medication schedule. Sleep is protected. Meals are small and frequent. Ambulation is encouraged as tolerated. The clinical team stays close, and any adjustment to a benzodiazepine taper during this window is made conservatively and reviewed against the guest's response rather than the calendar.
Discharge Criteria and Aftercare Handoff
Detox is complete when withdrawal has stabilized for a sustained window, vitals are stable, sleep is regulated, and the guest can hydrate and eat without support. For a benzodiazepine taper still in progress at discharge, completion means the remaining schedule is documented, conservative, and has an identified prescriber at home to continue it — tapering off this medication class is not something that should ever be finished on a plane or compressed to fit a departure date. Meeting discharge criteria is a clinical judgment, not a calendar date, and it varies meaningfully between guests.
Discharge planning is not a departure task — it starts in the middle of week one. Every guest leaves with a written aftercare plan: referrals for continued clinical care in their home city, a maintenance IV and nutrition protocol, and structured integration check-ins for the first months. See what to expect at a luxury rehab and, for guests whose taper involves a controlled medication, our luxury benzo detox program.
References
- National Institute on Alcohol Abuse and Alcoholism. Understanding alcohol use disorder.
- Caputo F, et al. Alcohol withdrawal syndrome in hospitalized patients: a practical review. Eur J Intern Med. 2026;107103.
- National Institute on Drug Abuse. Treatment approaches for drug addiction.
- U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. 2020.
- Horowitz M, et al. Pharmacological principles for safe benzodiazepine and Z-drug dose reduction. Psychol Med. 2026;56:e198.
- Brandt J, et al. Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: a modified Delphi study. Ther Adv Psychopharmacol. 2026;16.
- StatPearls. Benzodiazepine withdrawal management. NCBI Bookshelf.
- Park K, et al. Effectiveness of psychosocial interventions for drug use disorders in inpatient settings: a systematic review. Subst Use Misuse. 2026.


